Retro biosciences stock price

Bloomberg -- Sam Altman became the face of the artificial intelligence craze through his role as chief executive officer of OpenAI. But his wealth goes far beyond the startup behind ChatGPT.

It had set up its headquarters in a raw warehouse space near San Francisco just the year before, bolting shipping containers to the concrete floor to quickly make lab space for the scientists who had been enticed to join the company. But it was vague about where its money had come from. Altman spends nearly all his time at OpenAI , an artificial-intelligence company whose chatbots and electronic art programs have been convulsing the tech sphere with their human-like capabilities. It is among the largest ever by an individual into a startup pursuing human longevity. Altman has long been a prominent figure in the Silicon Valley scene, where he previously ran the startup incubator Y Combinator in San Francisco.

Retro biosciences stock price

This means our website may not look and work as you would expect. Read more about browsers and how to update them here. Invest now. To buy shares in , you'll need to have an account. Explore the options. The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation. You are here:. Market closed Prices as at close on 12 March Switch to live prices. Deal now.

Rico Meinl Bioinformatics Trainee.

Private longevity research companies deserve investor attention as the longevity side of the life science market grows. Longevity research companies are working to promote healthy aging and extend life expectancy. A long, healthy life is something everyone has a vested interest in, but that doesn't mean it's always easy to get into longevity investing. Many longevity research companies remain private, meaning it's difficult for the average person to secure a stake. However, investors shouldn't ignore private longevity research companies.

Another mysterious longevity company has come out of stealth with the backing of hundreds of millions of dollars. If you are wondering who the investors are that have put up this large round of funding, get in line. For right now, the company is staying tight lipped on exactly where the money is from. The company is focused on three, distinct areas to start: cellular reprogramming, plasma-inspired therapeutics, and autophagy. The autophagy program will enter the clinic as soon as next year. Some researchers believe that increased autophagy could result in increased lifespan. By focusing on the cellular drivers of aging, Retro will produce therapeutics eventually capable of multi-disease prevention. Other startups include:.

Retro biosciences stock price

Thanks for contacting us. We've received your submission. Altman — the recently-reinstated CEO of ChatGPT-maker OpenAI — reportedly mulled funding a smaller longevity-technology-focused company around a single therapy that followed the more traditional route of chasing a singular breakthrough that one day heads into clinical trials and sell its results to a pharmaceutical or medical device giant.

Chase carlson nude

Altos sucked up half the leading scientists in reprogramming when it convinced two dozen university professors to leave their jobs, offering million-dollar salaries, among other benefits. Our cellular reprogramming effort is closest to fundamental research and farthest upstream in the mechanisms of aging. Artificial Intelligence. How to Invest in Genetics:. Shirley Telebrico. The resulting programs can, in just seconds, create pictures and complex text passages that pass for the work of humans. Mohamed Yafia. He graduated magna cum laude in Molecular Biology, leaving college early to work on his startup full-time. Peng Liu, PhD, joined Retro in February with his passion on cellular reprogramming and tissue rejuvenation. She is a travel enthusiast and enjoys time with her family. Melissa Pistilli has been reporting on the markets and educating investors since To support these three programs, we are investing heavily in single-cell multi-omics, machine-learning-based computational biology, and lab automation. Scientist in Cell Biology.

From Jeff Bezos to Jack Dorsey, billionaires are using their wealth to fight aging.

Bry is a graduate of the University of Texas at Austin with a degree in Biochemistry and minor in Business Foundations. Mahmoud Dabbah. By the time Retro came out of stealth, though, the assault on old age was going through a period of intense popularity. Dividend yield : 0. Learn about our editorial policies. One of its projects is to test rejuvenation techniques on T cells, part of the immune system that play an important role in fighting infection and staving off cancer. Joe spent 2. News and fundamental data provided by Digital Look. Insilico Medicine Hong Kong-based Insilico Medicine is a clinical-stage biotech company harnessing the power of artificial intelligence AI , big data analysis and genomics for researching aging and developing medicines that target cancers, infectious diseases, autoimmune diseases, central nervous system diseases and age-related diseases. Throughout his time with SFO airport he received numerous training and assignments involving animals being transported throughout the country in cargo planes while maintaining a managerial position and overlooking the work of 12 employees. Ben Ray Lab Automation Engineer. Alejandra Sevilla Senior Research Associate. At Retro Dunja is working on imaging analysis pipelines and capturing aging and rejuvenation effects through multi-omics methodologies. Every technology also has risks. Leslie has worked at the Jackson Laboratory characterizing surgical models funded by the California Institute of Regenerative Medicine, and at the UC Davis Mouse Biology Program where she optimized and validated bariatric surgical models.